Zrakovi says the extra weight affected his blood sugar and blood pressure, which led to a GLP-1 treatment story from the McLaren team.
Recap by typeshit. Full story at McLaren Health Care.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
11:37
A 63 year old creator walks through six months on tirzepatide and a 48 pound drop, sharing a personal account of the experience.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
New EASD analyses, not yet peer reviewed, found about 13 to 14% weight loss at the 36 mg dose and an indirect edge over high-dose oral semaglutide in diabetes.
Partnership for Safe Medicines also notes Eli Lilly suing five more retatrutide sellers and FDA staff concerns over a plan to let compounders dispense unapproved peptides.
Loading…